CIAS

(redirected from Cognitive Impairment Associated with Schizophrenia)
AcronymDefinition
CIASCentro de Investigación y Acción Social (Spanish: Center for Social Action and Research; Buenos Aires, Argentina)
CIASCentre Intercommunal d'Action Sociale (French: Intermunicipal Center for Social Action)
CIASCenter for Integrated Agricultural Systems (UW-Madison)
CIASCenter for Infrastructure Assurance and Security (University of Texas, San Antonio)
CIASCenter for Integrated Area Studies (Kyoto University; Japan)
CIASCanadian International Auto Show
CIASChangi International Airport Services (Singapore)
CIASCertified Investment Agent Specialist (real estate industry)
CIASCanadian International Air Show
CIASCognitive Impairment Associated with Schizophrenia
CIASCenter for Information Assurance and Security (University of Texas, Austin)
CIASCounterintelligence Analysis Section (US DoD)
CIASConseil International de l'Action Sociale
CIASCenter for International and Area Studies
CIASCenter for Investment Advisory Services
CIASCollege of Imaging Arts and Science (Rochester Institute of Technology)
CIASComputer Imaging Analysis Software
CIASCircuit Inventory & Analysis System
References in periodicals archive ?
The report provides comprehensive information on the therapeutics under development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The report provides a snapshot of the global therapeutic landscape of Cognitive Impairment Associated With Schizophrenia (CIAS)
The report reviews pipeline therapeutics for Cognitive Impairment Associated With Schizophrenia (CIAS) by companies and universities/research institutes based on information derived from company and industry-specific sources
This report provides comprehensive information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
The report reviews key players involved in the therapeutics development for Cognitive Impairment Associated With Schizophrenia (CIAS) and enlists all their major and minor projects
This programme represents a unique approach to the treatment of cognitive impairment associated with schizophrenia and other disorders, Mates added.
Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014
Full browser ?